Trend Press Wire

Personalized Medicine Market By Development, Trends, Investigation 2019 And Forecast To 2026

Press release   •   Nov 08, 2019 07:32 EST

The global Personalized Medicine Market is projected to grow at an annual rate of almost 9.1% over the forecast time frame 2019 to 2026, according to ARC. The global based market intelligence company expects the market to reach a value of around $1.7 trillion by 2026.

Acumen Research and Consulting has recently published a research report on the Personalized Medicine Market for the forecast period of 2019 to 2026, The report provides rational insights along with historical and forecast data that aids in better understanding of the global scenario of Personalized Medicine Market. The report provides a comprehensive analysis of the factors that are expected to drive and restrict the growth of the market. It also provides the detailed overview of the opportunities that are present in the market along with the current trends observed in the target market. The report includes a complete study of quantitative analysis of the industry for the period of 8 years in order to assist players to take advantage of the report. The report includes widespread analysis of the key segments of the industry that help for better understanding of the current trends and opportunities in this research report.

The Porters Five Forces analysis is included in the report, provides insights on the overall scenario from buyers and suppliers point-of-view. The regulatory compliances provide insight of the various government rules and regulations on various products and services and the way it affects the various end use industry.

Market Participants / Key Players:

The report cover the major players operating in the target market along with the key strategies adopted in order to get a competitive edge against the competitors which provides a competitive outlook of the industry. The report provides a competitive landscape that includes insights of the positioning of players on global level through mapping the business and product offering strength.

Several players, including Illumina, Inc.; Danaher Corporation Asuragen, Inc.; Abbott Laboratories; GE Healthcare; Dako A/S; Exagen Diagnostics, Inc.; Exact Science Corporation;Decode Genetics, Inc.; QIAGEN; Celera Diagnostics LLC; Genelex Corporation; Precision Biologics, Inc.; and Biogen, Inc. companies, research institutes, contract manufacturing organizations, and non-profit organizations, are playing a critical role in the development and production of these vectors.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1466

Scope of the Personalized Medicine Market Report:

The study provides a decisive view of the Personalized Medicine Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It also provides country wise segmentation and the factors that are driving the regional growth.

Market Segmentation:

Market, By Product

  • Therapeutics
  • Diagnostics
  • Personalized Nutrition & Wellness
  • Personalized Medical Care

Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Personalized Medicine Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Personalized Medicine market segments with market dynamics and their impact. The report also covers basic technology development policies.

This Report offers an assessment of the most recent developments in each sub-segment from 2015 until 2026 and offers a forecast of revenues and volume growth at worldwide, regional and national levels. ARC segmented the worldwide personalized medicine (PM) report on the product and region for the purpose of this research:

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Personalized Medicine
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Personalized Medicine Market By Product
1.2.2.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Personalized Medicine Market Revenue Share By Product in 2017
1.2.2.3. Therapeutics
1.2.2.4. Diagnostics
1.2.2.5. Personalized Nutrition & Wellness
1.2.2.6. Personalized Medical Care
1.2.3. Personalized Medicine Market by Geography
1.2.3.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Personalized Medicine Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Personalized Medicine Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Personalized Medicine Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Personalized Medicine Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Personalized Medicine Major Manufacturers in 2017

CHAPTER 4. PERSONALIZED MEDICINE MARKET BY PRODUCT

4.1. Global Personalized Medicine Revenue By Product
4.2. Therapeutics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Diagnostics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Personalized Nutrition & Wellness
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Personalized Medical Care
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY

5.1. North America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Personalized Medicine Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE PERSONALIZED MEDICINE MARKET BY COUNTRY

6.1. Europe Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET BY COUNTRY

7.1. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY

8.1. Latin America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST PERSONALIZED MEDICINE MARKET BY COUNTRY

9.1. Middle East Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA PERSONALIZED MEDICINE MARKET BY COUNTRY

10.1. Africa Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Illumina, Inc.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Danaher Corporation
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Asuragen, Inc.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. GE Healthcare
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Dako A/S
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Exagen Diagnostics, Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Exact Science Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Decode Genetics, Inc.
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. QIAGEN
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Celera Diagnostics LLC
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Genelex Corporation
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Precision Biologics, Inc.
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
11.14. Biogen, Inc.
11.14.1. Company Snapshot
11.14.2. Overview
11.14.3. Financial Overview
11.14.4. Product Portfolio
11.14.5. Key Developments
11.14.6. Strategies
11.15. Others
11.15.1. Company Snapshot
11.15.2. Overview
11.15.3. Financial Overview
11.15.4. Product Portfolio
11.15.5. Key Developments
11.15.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1466

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.